Monoclonal antibody treatments
Monoclonal antibodies, or mAbs, are made in a laboratory to fight a particular infection in this case, SARS-CoV-2) and are given to you directly in an infusion. So the mAb treatment may help if you are at high risk for serious symptoms or a hospital stay.
Related Conference of Monoclonal antibody treatments
August 21-22, 2024
5th International conference on Vaccines, Vaccination and Immunization
Paris, France
September 12-13, 2024
19th International Conference on Allergic Diseases and Clinical Immunology
Paris, France
October 24-25, 2024
5th International Conference on Immunology And Immunotherapy
Zurich, Switzerland
Monoclonal antibody treatments Conference Speakers
Recommended Sessions
- Cardiac manifestations of coronavirus
- Coronaviruses (COVID-19)
- COVID-19 and Environmental Health
- COVID-19 Clinical Trails
- COVID-19 Drug design and Development
- Epidemiological Characteristics of COVID-19
- Food and Nutrition
- Genomics and transmissibility
- Infectious Diseases Covid-19
- Mental health
- Monoclonal antibody treatments
- Omicron
- SARS-CoV-2 variants
- Severe Acute Respiratory Syndrome Coronavirus 2
- Therapeutics and COVID-19
- Vaccines
- Virology
Related Journals
Are you interested in
- Advances in Molecular Immunology - Allergic Conference 2024 (France)
- Allergen Identification and Characterization - Allergic Conference 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - Allergic Conference 2024 (France)
- Cancer Immunology and Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Case Studies in Allergy Diagnosis and Management - Allergic Conference 2024 (France)
- Cell & Plant Biology - IMMUNOLOGY 2024 (Spain)
- Cell Biology - IMMUNOLOGY 2024 (Spain)
- CELL, ANIMAL & PLANT BIOLOGY - IMMUNOLOGY 2024 (Spain)
- Clinical Immunology & Current & Future Research - IMMUNOLOGY 2024 (Spain)
- Clinical Trials and Translational Research in Allergy and Immunology - Allergic Conference 2024 (France)
- Digital Health and Telemedicine in Allergy Care - Allergic Conference 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - Allergic Conference 2024 (France)
- Immune Responses to Vaccination - Allergic Conference 2024 (France)
- Immune System - IMMUNOLOGY 2024 (Spain)
- Immuno informatics & Systems immunology - IMMUNOLOGY 2024 (Spain)
- Immuno-Genetics - IMMUNOLOGY 2024 (Spain)
- Immunogenetics - IMMUNOLOGY 2024 (Spain)
- Immunogenetics and Allergic Susceptibility - Allergic Conference 2024 (France)
- Immunohistochemistry - IMMUNOLOGY 2024 (Spain)
- Immunological Aspects of Drug Allergies - Allergic Conference 2024 (France)
- Immunological Basis of Food Allergy - Allergic Conference 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - Allergic Conference 2024 (France)
- Immunology - IMMUNOLOGY 2024 (Spain)
- Immunomodulation in Allergy Management - Allergic Conference 2024 (France)
- Immunopathogenesis of Allergic Diseases - Allergic Conference 2024 (France)
- Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Immunotherapy for Allergic Conditions - Allergic Conference 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - Allergic Conference 2024 (France)
- Mechanisms of Immunodeficiency Diseases - Allergic Conference 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - Allergic Conference 2024 (France)
- Nutritional Immunology - IMMUNOLOGY 2024 (Spain)
- OncoImmunology - IMMUNOLOGY 2024 (Spain)
- Pediatric and Neonatal Immunology - IMMUNOLOGY 2024 (Spain)
- Reproductive Immunology - IMMUNOLOGY 2024 (Spain)
- Role of Microbiota in Allergic Disorders - Allergic Conference 2024 (France)
- Transplantation and Computational Immunology - IMMUNOLOGY 2024 (Spain)
- Vaccines & Immunization - IMMUNOLOGY 2024 (Spain)
- Virology and infectious diseases - IMMUNOLOGY 2024 (Spain)